The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The prognostic impact of immune-related adverse events in real-world patients with metastatic melanoma treated with single-agent and combination immune checkpoint blockade.
 
Alexander Watson
No Relationships to Disclose
 
Siddhartha Goutam
No Relationships to Disclose
 
Igor Stukalin
No Relationships to Disclose
 
Benjamin Ewanchuk
No Relationships to Disclose
 
Michael Sander
Consulting or Advisory Role - Abbvie (I); Amgen (I); Aralez Pharmaceuticals (I); Celgene (I); Galderma (I); Janssen (I); Johnson & Johnson/Janssen (I); L'Oreal (I); LEO Pharma (I); Novartis (I); Sanofi (I); UCB (I); Vichy (I); Vichy (I)
 
Daniel E. Meyers
No Relationships to Disclose
 
Aliyah Pabani
Consulting or Advisory Role - AstraZeneca Canada; Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb
 
Winson Y. Cheung
No Relationships to Disclose
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
Tina Cheng
No Relationships to Disclose
 
Jose Gerard Monzon
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche Canada; Sanofi; Taiho Oncology
Speakers' Bureau - EMD Serono; Merck; Novartis
Research Funding - Merck (Inst)
 
Vishal Navani
Speakers' Bureau - Ekas; Ipsos; Kyowa Kirin